ARCHIVES

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

This article is from The Cancer Letter archive.

Vol. 23 No. 39 | October 10, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Seeking Industry Support Again For Summer Program Congress Oks Smokeless Tobacco Bill

February 14, 1986

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997

Greenwald: Report’s Implementation Will Require Budget Raise

June 27, 1997

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

September 5, 2008

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001